Product Comparison


  Sanofi Aventis 00024586201 Amneal Pharmaceuticals LLC 70121169402 Pfizer Biosimilar 00069029101 Pfizer Biosimilar 00069029201

No Image

McKesson # 1109658 1236824 1155119 1155120 1140103
Description Mozobil® Plerixafor 24 mg Injection Single-Dose Vial 1.2 mL Plerixafor 20 mg / mL Injection Single-Dose Vial 1.2 mL Nivestym® Filgrastim-aafi 300 mcg / 0.5 mL Injection Prefilled Syringe 0.5 mL Nivestym® Filgrastim-aafi 480 mcg / 0.8 mL Injection Prefilled Syringe 0.8 mL Zarxio® Filgrastim-sndz 480 mcg / 0.8 mL Injection Prefilled Syringe 0.8 mL
Manufacturer # 0002458620170121169402000690291010006902920161314032610
Brand Mozobil® Nivestym®Nivestym®Zarxio®
Manufacturer Sanofi AventisAmneal Pharmaceuticals LLCPfizer BiosimilarPfizer BiosimilarSandoz
Invoice MOZOBIL, VL 20MG/MLPLERIXAFOR, SDV 20MG/ML 1.2MLNIVESTYM, PFS 300MCG/0.5MLNIVESTYM, PFS 480MCG/0.8MLZARXIO, PFS 480MCG/0.8ML (10/CT)
    Log In to Order   Log In to Order   Log In to Order   Log In to Order   Log In to Order

Comparison

Alternate Manufacturer Number 2054708254961625496813796828
Container Type Single-Dose VialSingle-Dose VialPrefilled SyringePrefilled SyringePrefilled Syringe
Generic Drug Code 1612416124451034510438082
Generic Drug Name PlerixaforPlerixaforFilgrastim-aafiFilgrastim-aafiFilgrastim-sndz
NDC Number 0002458620170121169402000690291010006902920161314032610
Product Dating McKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 90 daysMcKesson Acceptable Dating: we will ship >= 180 days
Storage Requirements Requires RefrigerationRequires RefrigerationRequires Refrigeration
Strength 24 mg20 mg / mL300 mcg / 0.5 mL480 mcg / 0.8 mL480 mcg / 0.8 mL
Type SubcutaneousSubcutaneousIntravenous or SubcutaneousIntravenous or Subcutaneous
UNSPSC Code 5113152051131520512018025120180251201802
Volume 1.2 mL1.2 mL0.5 mL0.8 mL0.8 mL
Application Hematopoietic AgentHematopoietic AgentHematopoietic AgentHematopoietic AgentHematopoietic Agent
Country of Origin UnknownUnknownUnknownUnknownUnknown
Dosage Form InjectionInjectionInjectionInjectionInjection
Features and Benefits
  • Plerixafor injection, a hematopoietic stem cell mobilizer, is indicated in combination with granulocyte-colony stimulating factor (G-CSF) to mobilize hematopoietic stem cells (HSCs) to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma or multiple myeloma